Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Wyles

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2005
Abacavir pharmacokinetics in hepatic dysfunctionDavid L Wyles, John G Gerber
Topics in Antiviral Medicine|August 19, 2017
Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future RegimensDavid L Wyles, Anne F Luetkemeyer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2016
Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral TherapyDavid L Wyles, Mark S Sulkowski, Douglas Dieterich
BMC Pulmonary Medicine|April 3, 2026
Effect of MN-166 (ibudilast) on acute respiratory failure prevention in hospitalized participants with COVID-19: a randomized, double-blind, placebo-controlled phase 2 studyDavid L Wyles, Kazuko Matsuda, Yuichi Iwaki, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2008
Synergy of a hepatitis C virus (HCV) NS4A antagonist in combination with HCV protease and polymerase inhibitorsDavid L Wyles, Kelly A Kaihara, Robert T Schooley
Chembiochem : a European Journal of Chemical Biology|June 22, 2010
A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry siteMaia Carnevali, Jerod Parsons, David L Wyles, et al.
Journal of Virology|December 22, 2006
Synergy of small molecular inhibitors of hepatitis C virus replication directed at multiple viral targetsDavid L Wyles, Kelly A Kaihara, Florin Vaida, et al.
The Journal of Infectious Diseases|January 4, 2008
3-drug synergistic interactions of small molecular inhibitors of hepatitis C virus replicationChristian Grünberger, David L Wyles, Kelly A Kaihara, et al.
Open Forum Infectious Diseases|January 16, 2026
Evaluation of Liver Fibrosis Change After DAA-induced Cure of Hepatitis C in Participants With and Without HIV: ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (VHICS)Marion G Peters, Minhee Kang, Robert Murphy, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Functional conservation despite structural divergence in ligand-responsive RNA switchesMark A Boerneke, Sergey M Dibrov, Jing Gu, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2005
Abacavir pharmacokinetics in hepatic dysfunctionDavid L Wyles, John G Gerber
Topics in Antiviral Medicine|August 19, 2017
Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future RegimensDavid L Wyles, Anne F Luetkemeyer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2016
Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral TherapyDavid L Wyles, Mark S Sulkowski, Douglas Dieterich
BMC Pulmonary Medicine|April 3, 2026
Effect of MN-166 (ibudilast) on acute respiratory failure prevention in hospitalized participants with COVID-19: a randomized, double-blind, placebo-controlled phase 2 studyDavid L Wyles, Kazuko Matsuda, Yuichi Iwaki, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2008
Synergy of a hepatitis C virus (HCV) NS4A antagonist in combination with HCV protease and polymerase inhibitorsDavid L Wyles, Kelly A Kaihara, Robert T Schooley
Chembiochem : a European Journal of Chemical Biology|June 22, 2010
A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry siteMaia Carnevali, Jerod Parsons, David L Wyles, et al.
Journal of Virology|December 22, 2006
Synergy of small molecular inhibitors of hepatitis C virus replication directed at multiple viral targetsDavid L Wyles, Kelly A Kaihara, Florin Vaida, et al.
The Journal of Infectious Diseases|January 4, 2008
3-drug synergistic interactions of small molecular inhibitors of hepatitis C virus replicationChristian Grünberger, David L Wyles, Kelly A Kaihara, et al.
Open Forum Infectious Diseases|January 16, 2026
Evaluation of Liver Fibrosis Change After DAA-induced Cure of Hepatitis C in Participants With and Without HIV: ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (VHICS)Marion G Peters, Minhee Kang, Robert Murphy, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Functional conservation despite structural divergence in ligand-responsive RNA switchesMark A Boerneke, Sergey M Dibrov, Jing Gu, et al.
Pageof 8